Congrats to our 2022 annual Extra-VOR-dinary awards winners, Jianxin Hu, Eric Berglund, and Kayti Conger! These #Voracians were recognized for their momentous contributions to our organization and their unshakable embodiment of our core values. Thank you for all you do!

Our President & CEO, Robert Ang sat down with @LifeSciLeader1 executive editor, Wayne Koberstein to discuss how Vor Bio transitioned its novel approach from the lab to a first-in-human clinical trial. Read the full article here: lifescienceleader.com/doc/vor-bio-s-… #bloodcancer

Congratulations to John, Amber Tong & the rest of the Endpoints News team. Excited to see what comes next!

#Voracians came together last week to celebrate MLB #OpeningDay with some friendly competition. Great work by our Manufacturing, Science & Technology team for coming up with this idea for our latest #VorPour. Teams tested their pitching arms for a chance to win a #RedSox hat!

This week at #CGMed23, our President & CEO, Robert Ang will participate in a panel on “Planning for CGT Commercial Readiness: Adaptive Manufacturing Strategy.” Learn more: meetingonthemed.com Cc Alliance for Regenerative Medicine (ARM)

Looking forward to Alliance for Regenerative Medicine (ARM)’s #CGMed23!

It was a privilege to present @VorBioPharma at the Alliance for Regenerative Medicine (ARM)'s @meetingont Meeting on the Med today! What a wonderful gathering of cell and gene therapy leaders from all corners of the globe.

At #VorBio, we’re proud to support blood #stemcell registries like DKMS US. This week, #Voracians learned about the different registries as well as about opportunities to help raise awareness or become a donor for patients in need

Proud to work with partners like @BeTheMatch who are working to remove barriers to increase access to #bloodstemcelltransplants #NationalMinorityCancerAwareness

We are honored to be named one of the Best Places to Work by Boston Business Journal. At #VorBio, our values of Passion, Fellowship & Humility guide us in our mission to transform #bloodcancer treatment. Thank you to our incredible team for working each day to achieve this goal 👏

We’re proud to share that our very own Tirtha Chakraborty, PhD was named to the The Medicine Maker #PowerList2023, recognizing his dedication and passion for transforming #bloodcancer treatments. Congratulations, Tirtha! 👏 Learn more about the honor: themedicinemaker.com/awards/power-l…

Today is #AMLWorldAwarenessDay. Did you know that the clinical approach to treat #AML has not significantly changed in decades? At #VorBio, we’re aiming to transform the standard of care with next-generation transplants for #bloodcancer patients.

We’re thrilled to announce that the FDA has cleared our IND application for VCAR33, a T-cell therapy derived from allogeneic healthy donors that targets CD33.

Tomorrow, our CFO, Nathan Jorgensen, PhD, and CSO, Tirtha Chakraborty, PhD, will discuss #VorBio’s novel therapeutic approach for #AML and weigh in on #biotech hot topics at Stifel’s Boston Biotech Bus Tour

Exciting news for Vor Bio. Thank you to Edita Smajic Broad Institute and Harvard Medical School for making #geneediting technology broadly available and making it possible for companies like #VorBio to bring #CRISPR-based drugs to patients in need of new treatments.

We were excited to be at the Cold Spring Harbor Laboratory Meeting on Genome Engineering: #CRISPR Frontiers! Our team presented a data resource created to evaluate the application of single cell DNA sequencing to #geneediting #CSHLCRISPR23

What a privilege it is to be named alongside such great leaders and innovators. Of course, it's easy to lead such a phenomenal team at Vor Bio!

So exciting to provide new data demonstrating our proof-of-concept for our gene-modified shielded HSC transplants and targeted therapy!

#VorBio CEO Robert Ang recently joined Luke Timmerman on The Long Run podcast to discuss our novel approach that aims to use gene-edited hematopoietic cell transplants to transform outcomes for patients with #AML. Listen to the podcast here: buff.ly/4866xiR

What an amazing opportunity to sit down with the great Luke Timmerman to tell my story and the story of Vor. It's hard to understand how Luke has the bandwidth to do such great reporting while traversing Kilimanjaro and raising millions for cancer therapies and poverty. Thank you!